FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component

48798 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Existential restriction modifier (core metadata concept)
Members targetComponentId
pT2b category American Joint Committee on Cancer pT2b (qualifier value)
pT2b category American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor invades choroid focally (retinoblastoma) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor invades choroid focally (retinoblastoma) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor invades deep muscle (outer half) (urinary bladder) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor invades deep muscle (outer half) (urinary bladder) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor invades subserosa (stomach) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor invades subserosa (stomach) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) American Joint Committee on Cancer pT2b (qualifier value)
pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) American Joint Committee on Cancer pT2b (qualifier value)
pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT2c (qualifier value)
pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT2c (qualifier value)
pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT2c (qualifier value)
pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT2c (qualifier value)
pT2c category American Joint Committee on Cancer pT2c (qualifier value)
pT2c category American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Bilateral disease (prostate) American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Bilateral disease (prostate) American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT2c (qualifier value)
pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT2c (qualifier value)
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) pT3 (AJCC)
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) pT3 (AJCC)
pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) pT3 (AJCC)
pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) pT3 (AJCC)
pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) pT3 (AJCC)
pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) pT3 (AJCC)
pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) pT3 (AJCC)
pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) pT3 (AJCC)
pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) pT3 (AJCC)
pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) pT3 (AJCC)
pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) pT3 (AJCC)
pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) pT3 (AJCC)
pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) pT3 (AJCC)
pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) pT3 (AJCC)
pT3 category pT3 (AJCC)
pT3 category pT3 (AJCC)
pT3: Discontinuous tumors in the primary bone site (bone) pT3 (AJCC)
pT3: Discontinuous tumors in the primary bone site (bone) pT3 (AJCC)
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) pT3 (AJCC)
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) pT3 (AJCC)
pT3: Extraprostatic extension (prostate) pT3 (AJCC)
pT3: Extraprostatic extension (prostate) pT3 (AJCC)
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) pT3 (AJCC)
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) pT3 (AJCC)
pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) pT3 (AJCC)
pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) pT3 (AJCC)
pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) pT3 (AJCC)
pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) pT3 (AJCC)
pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) pT3 (AJCC)
pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) pT3 (AJCC)
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas) pT3 (AJCC)
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas) pT3 (AJCC)
pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) pT3 (AJCC)
pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) pT3 (AJCC)
pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) pT3 (AJCC)
pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) pT3 (AJCC)
pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) pT3 (AJCC)
pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) pT3 (AJCC)
pT3: Tumor invades adventitia (esophagus) pT3 (AJCC)
pT3: Tumor invades adventitia (esophagus) pT3 (AJCC)
pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) pT3 (AJCC)
pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) pT3 (AJCC)
pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) pT3 (AJCC)
pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) pT3 (AJCC)
pT3: Tumor invades beyond muscularis into periureteric fat (ureter) pT3 (AJCC)
pT3: Tumor invades beyond muscularis into periureteric fat (ureter) pT3 (AJCC)
pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) pT3 (AJCC)
pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) pT3 (AJCC)
pT3: Tumor invades pancreas (ampulla of Vater) pT3 (AJCC)
pT3: Tumor invades pancreas (ampulla of Vater) pT3 (AJCC)
pT3: Tumor invades perivesical tissue (urinary bladder) pT3 (AJCC)
pT3: Tumor invades perivesical tissue (urinary bladder) pT3 (AJCC)
pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts) pT3 (AJCC)
pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts) pT3 (AJCC)
pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis) pT3 (AJCC)
pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis) pT3 (AJCC)
pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix) pT3 (AJCC)
pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix) pT3 (AJCC)
pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum) pT3 (AJCC)
pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum) pT3 (AJCC)
pT3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine) pT3 (AJCC)
pT3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine) pT3 (AJCC)
pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma) pT3 (AJCC)
pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma) pT3 (AJCC)
pT3: Tumor involves bony structures and/or paranasal sinuses (nasopharynx) pT3 (AJCC)

Start Previous Page 485 of 488 Next End

Reference Sets

Reference set descriptor

Back to Start